Text Size
389 studies found for:    Open Studies | "Anticoagulants"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention;   Drug: Dalteparin
2 Recruiting Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
3 Recruiting Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Condition: Idiopathic Venous Thromboembolism
Intervention: Other: Application of the"Men continue and HER DOO2" rule
4 Recruiting Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
5 Recruiting Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
6 Recruiting Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
7 Unknown † Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
8 Unknown † rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
9 Recruiting Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
10 Recruiting Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
11 Unknown † D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium
12 Recruiting SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
Conditions: Stroke, Acute;   Atrial Fibrillation
Intervention: Other: This is an observational study.
13 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
14 Recruiting Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Condition: No High Risk of Hemorrhage
Intervention: Device: Intermittent pneumatic compression of the lower limbs
15 Not yet recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
16 Recruiting Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)
Conditions: Ischemic Stroke;   Intracranial Hemorrhage
Intervention:
17 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
18 Recruiting Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study
Condition: Clot Formation and Platelet Aggregation in Point of Care Testing
Intervention:
19 Recruiting EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Interventions: Other: Genotype-guided dosing algorithm;   Other: Non-genotype-guided dosing algorithm
20 Unknown † Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years